SIBO - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Restless Leg Syndrome - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

This lecture starts with the known and newer pathophysiology to try to uncover new ways of treating restless legs syndrome (RLS). Using case studies, he links RLS with small intestinal bacterial overgrowth (SIBO), low iron, and other autoimmune disorders. Treatment examples are provided

Atopic Dermatitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Atopic dermatitis is a hereditary skin disorder, and the most common form of eczema. Dr. Smith reviews the pathophysiology and diagnostic criteria for atopic dermatitis, as well as some causes.

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Leonard Weinstock, MD - Mast cell activation syndrome and potential role for LDN (2019 Conference) (LDN, low dose naltrexone)

Leonard Weinstock, MD discusses LDN  for MCAS and SIBO at the LDN 2019 Conference. He discusses the etiology, symptoms, testing, and therapy for MCAS, SIBO, and POTS; and presents related cases.
 

Dana Keaton, ND - The scope of patient selection for LDN (2019 Conference) (LDN, low dose naltrexone)

Jill Brook, MA, LDN Radio Show 12 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Leonard Weinstock, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Leonard Weinstock shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.

Dr John Kim, LDN Radio Show 07 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we're joined by Dr John Kim. Thank you for joining us, John.

Dr John Kim: Well, thank you for the invitation, Linda,